Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Colin A. Hutchison"'
Autor:
Manish Kaushik, Peter Stenvinkel, Kianoush Kashani, Ziad A. Massy, Li Zuo, Faeq Husain-Syed, Thiago Reis, Peter J. Blankestijn, Hideki Kawanishi, Colin A. Hutchison, Raymond Vanholder, Laurent Juillard, Claudio Ronco, Mario Cozzolino, Mitchell H. Rosner, Tammy L. Sirich
Publikováno v:
Clinical Journal of the American Society of Nephrology
Clinical Journal of the American Society of Nephrology, American Society of Nephrology, 2021, pp.CJN.02660221. ⟨10.2215/cjn.02660221⟩
Clin J Am Soc Nephrol
Clinical Journal of the American Society of Nephrology, 2021, pp.CJN.02660221. ⟨10.2215/cjn.02660221⟩
Clinical Journal of the American Society of Nephrology, American Society of Nephrology, 2021, pp.CJN.02660221. ⟨10.2215/cjn.02660221⟩
Clin J Am Soc Nephrol
Clinical Journal of the American Society of Nephrology, 2021, pp.CJN.02660221. ⟨10.2215/cjn.02660221⟩
International audience; Advances in our understanding of uremic retention solutes, and improvements in hemodialysis membranes and other techniques designed to remove uremic retention solutes, offer opportunities to readdress the definition and classi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a347b62e193679a3fa2a88d48244a0b
https://www.hal.inserm.fr/inserm-03452101/document
https://www.hal.inserm.fr/inserm-03452101/document
Autor:
Julie Wessels, Markus Storr, Colin A. Hutchison, Mark Jesky, Paul Cockwell, Lesley Fifer, Christopher G. Winearls, Nils Heyne, Veronica Moroz, Julian D. Gillmore, Arthur R. Bradwell, Mark Cook, Katja Weisel
Publikováno v:
The Lancet Haematology. 6:e217-e228
Summary Background In multiple myeloma, severe acute kidney injury due to myeloma cast nephropathy is caused by pathogenic free light chain immunoglobulin in serum. High cutoff haemodialysis (HCO-HD) can remove large quantities of free light chain im
Autor:
Martin Wolley, Colin A. Hutchison
Publikováno v:
Nephrology Dialysis Transplantation
Patients with end-stage kidney disease (ESKD) on maintenance hemodialysis are subject to a high burden of inflammation and cardiovascular disease, driven at least in part by retention of uremic solutes. Existing dialysis technologies using high-flux
Autor:
Colin A. Hutchison, Adriana M Suarez, Rafael M. Sanabria, Jasmin Vesga, Ricardo Sánchez, J.G. Ariza
Publikováno v:
Nephron. 145(2)
Introduction: Expanded hemodialysis (HDx) effectively removes large middle molecular uremic toxins (>25 kDa) while still retaining albumin, potentially reducing their adverse effects. We compare the clinical laboratory parameters, hospitalization rat
Publikováno v:
The International journal of pharmacy practiceReferences. 28(6)
Objective Acute kidney injury (AKI) prevention strategies for community-acquired AKI associated with severe acute illness have received attention in recent years. The objective of this study was to evaluate a community pharmacist AKI education progra
Publikováno v:
Journal of Primary Health Care, Vol 12, Iss 3, Pp 244-256 (2020)
ABSTRACT INTRODUCTIONAwareness of the effect of acute kidney injury on patient outcomes and health systems is growing internationally. New Zealand’s approach focuses on stopping consumption of ‘at-risk’ medicines when acute kidney injury has be
Autor:
Elaine M. Pascoe, Anne Heath, Peter F Mount, Matthew A Roberts, Rathika Krishnasamy, Colin A. Hutchison, Nigel D Toussaint, Yeoungjee Cho, David W. Johnson, Muhgeot Wong, Peta-Anne Paul-Brent, Meg Jardine, Shaundeep Sen, Craig Nelson, Carmel M. Hawley, Liza A. Vergara
Publikováno v:
Blood purification. 49(4)
Background: A new class of dialysis membrane, the mid cut-off (MCO) dialyzer, has been developed to improve the clearance of uremic toxins in hemodialysis (HD). The a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains i
Autor:
Kym I E Snell, J. Pinney, Mark Jesky, Punit Yadav, Paul Cockwell, Stephanie Stringer, Mark Cook, Lesley Fifer, Kolitha Basnayake, Colin A. Hutchison, Mark T. Drayson
Publikováno v:
European Journal of Haematology. 96:610-617
Objectives The aim of this study was to report the long-term outcomes in patients with multiple myeloma (MM) who receive dialysis treatment for acute kidney injury (AKI) due to myeloma cast nephropathy and subsequently recover renal function. Methods
Dialysis technologies have continued to advance over recent decades; however, these advancements have not always been met with improved patient outcomes. In part, the high morbidity and mortality associated with dialysis have been attributed to a gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e91f5280e00d04c9ed2e03d2d48b374
https://europepmc.org/articles/PMC5969479/
https://europepmc.org/articles/PMC5969479/
Autor:
Maarten W. Taal, Scott Harris, Ziad A. Massy, A. Burmeister, Philip A. Kalra, Martin J Landray, Jonathan Emberson, S Liabeuf, Colin A. Hutchison, Fraser Sds., Paul Cockwell, Anthony Fenton, A Shardlow, James Ritchie
ObjectiveTo clarify the associations between polyclonal serum free light chain (sFLC) levels and adverse outcomes in patients with chronic kidney disease (CKD) by conducting a systematic review and individual patient data meta-analyses.Patients and M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9be9c05889d3cb004d73faff2c8687a
https://eprints.soton.ac.uk/413664/
https://eprints.soton.ac.uk/413664/